Fletcher/CSI Will Host an Unprecedented Four Sessions at the 2011 Pharma CI Conference and Exhibition

Share Article

Fletcher/CSI, LLC, experts in competitive intelligence and primary research, announced today that they will present four different sessions at the 2011 Pharma CI Conference and Exhibition. The conference will take place at the Sheraton Parsippany Hotel, NJ on September 13-14, 2011.

News Image
Our more than 20 years of experience allows our clients to outmaneuver and outperform their competitors.

Fletcher/CSI, LLC, experts in competitive intelligence and primary research, announced today that they will present four different sessions at the 2011 Pharma CI Conference and Exhibition. The conference will take place at the Sheraton Parsippany Hotel, NJ on September 13-14, 2011.

Erik Glitman, Fletcher/CSI’s CEO, stated that “Fletcher/CSI Healthcare Strategies is a trusted advisor to life science clients and a top choice provider of high-impact, competitive intelligence-based consulting services. Our more than 20 years of experience allows our clients to outmaneuver and outperform their competitors.”

On September 13th, Michael Martinolich, Vice President and Senior Consultant, will present "The Key to Survival and Building Competitive Advantage in the New World of Biologics and Biosimilars." Biologics represent some of the most costly drugs to develop and, in turn, are currently the most profitable on the market. Over the past three decades, with the advent of recombinant DNA technology, biologics have been an exponentially growing industry. Due to the vast spectrum of health benefits, biologics offer the industry continued growth; however, the exceedingly high cost of treatment has become an issue for payors and patients alike, putting pressure on manufacturers of both brand and biosimilar products.

In his interactive session, "Identifying Competitive Advantage through Learning from Adjacencies," on Wednesday, September 14th, Fletcher/CSI CEO Erik Glitman will present and discuss a process to learn from developments in adjacent markets and how those developments can serve as a powerful proxy for future developments in your own markets. Discussion will focus on how developments in technology, business models, and demand migrate across market boundaries.

Cinda Steele, Sr. VP Fletcher/CSI Healthcare Strategies, will present "How Developing Technologies will Change the Way you do Competitive and Market Intelligence." Given the competitive environment within the life science industry and the need to continually improve and reduce costs, many companies are looking for strategies to improve their business models and increase efficiencies. Recent technology improvements and developments are helping companies utilize effective and efficient tools to increase productivity, communications, and collaboration, while allowing for better analysis and decision making.

Monika Giese, Senior Consultant & Advisor Europe, Fletcher/CSI, will present "European Healthcare Systems - Lessons Learned," on Tuesday, September 13th. With the changes planned for the U.S. Healthcare System one can’t stop wondering how other nations are coping with exploding demographics and the increasing cost pressures. This presentation will take a closer look at selected European Healthcare Systems, their funding structure, the recent challenges and reforms introduced to beat bankruptcy.

Based on a foundation of therapeutic category expertise and functional life science business experience, Fletcher/CSI Healthcare Strategies utilizes competitor and market intelligence collection, analysis, and reporting to provide critical insight and recommendations to their clients. Understanding the marketplace and each client’s challenges gives Fletcher/CSI an advantage in helping clients identify, assess, and target critical industry movements and competitor tactical and strategic direction.

As the founder, lead sponsor, and co-coordinator of this event for over ten years, Fletcher/CSI has worked with our conference organizers to bring together a wealth of people, resources, and critical contemporary perspectives designed to address the industry’s current competitive challenges. The Pharma CI Conference and Exhibition has evolved into the leading forum and public platform for competitive intelligence thought in the pharmaceutical and device industries, and has also become the #1 networking event for life science managers and professionals.
To access the complete list of sessions or to register for the conference, please visit http://www.pharmaciconference.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lynda Engler
Visit website